Lumida
/KPTI
⌘K
Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

KPTI
$1.81USD+1.12%+0.02 today

MARKET CAP

40.6M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$11

Buying

4

institutions

Selling

8

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY1.42 M13.86 M+1.17 M+916.2%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL786.31 K7.68 M+-755.78 K-10.6%0.01%
MM

Millennium Management LLC

Q2 2026

SELL341.68 K3.34 M+-169.90 K+17.1%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY309.82 K3.03 M+97.45 K+155.9%0.02%
EP

Eversept Partners, LP

Q2 2026

SELL276.17 K2.70 M+-23.80 K+61.5%0.14%
JC

Jpmorgan Chase & Co

Q2 2026

BUY207.61 K2.09 M+207.14 K+83783.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL117.97 K1.15 M+-389.53 K-59.2%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY108.21 K1.06 M+2.80 K+80.1%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-341.94 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-170.75 K-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-30.00 K-100.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL0.000.00+-733.00-100.0%0.00%